The U.K. skin cancer 'two-week rule' proforma: Assessment of potential modifications to improve referral accuracy

British Journal of Dermatology

Volumn 158, Issue 6, 2008, Pages 1293-1298

  Cox, N H ^a   Madan, V ^a   Sanders, T ^a  

^a CUMBERLAND INFIRMARY   (United Kingdom)

Author keywords

Melanoma; Referral proforma; Squamous cell carcinoma; Two week rule

Indexed keywords

ACTINIC KERATOSIS; ARTICLE; CANCER SIZE; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SKIN CANCER; SQUAMOUS CELL CARCINOMA; UNITED KINGDOM;

CARCINOMA, SQUAMOUS CELL; ENGLAND; HUMANS; MELANOMA; PRACTICE GUIDELINES AS TOPIC; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; SPECIALTIES, MEDICAL; TIME FACTORS; WALES;

EID: 43749104615     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08519.x     Document Type: Article

References (16)

1. HM Government. The New NHS. Modern, Dependable (Government White Paper). The Stationery Office Ltd, 1997 7. Available at: http://www.archive.official- documents.co.uk/document/doh/newnhs/wpaper1.htm (last accessed 6 December 2007).
2. Department of Health. Cancer Referral Proforma. Suspected Skin Cancer Referral Form. Available at: http://www.dh.gov.uk (last accessed 6 December 2007).
3. MacKie RM. An Illustrated Guide to the Recognition of Early Malignant Melanoma. Glasgow, UK : Department of Dermatology, University of Glasgow, 1986.
4. Keefe M, Dick DC, Wakeel RA. A study of the value of the seven-point checklist in distinguishing benign pigmented lesions from melanoma. Clin Exp Dermatol 1990 15 : 167 71.
5. MacKie RM, Doherty VR. Seven-point checklist for melanoma. Clin Exp Dermatol 1991 16 : 151 3.
6. du Vivier AW, Williams HC, Brett JV, Higgins EM. How do malignant melanomas present and does this correlate with the seven-point check-list? Clin Exp Dermatol 1991 16 : 344 7.
7. Higgins EM, Hall P, Todd P et al. The application of the seven-point check-list in the assessment of benign pigmented lesions. Clin Exp Dermatol 1992 17 : 313 15.
8. Cox NH. Evaluation of the U.K. 2-week referral rule for skin cancer. Br J Dermatol 2004 150 : 291 8.
9. Thomson MA, Loffeld A, Marsden JR. More skin cancer detected from non-urgent referrals. Br J Dermatol 2005 153 : 453 4.
10. Healsmith MF, Bourke JF, Osborne JE, Graham-Brown RA. An evaluation of the revised seven-point checklist for the early diagnosis of cutaneous malignant melanoma. Br J Dermatol 1994 130 : 48 50.
11. Department of Health. Referral Guidelines for Suspected Cancer. Available at: http://www.dh.gov.uk (last accessed 6 December 2007).
12. McGovern TW, Litaker MS. Clinical predictors of malignant pigmented lesions. A comparison of the Glasgow seven-point checklist and the American Cancer Society's ABCDs of pigmented lesions. J Dermatol Surg Oncol 1992 18 : 22 6.
13. Liu W, Hill D, Gibbs AF et al. What features do patients notice that help to distinguish between benign pigmented lesions and melanomas?: the ABCD(E) rule versus the seven-point checklist. Melanoma Res 2005 15 : 549 54.
14. Cox NH. Dermatological aspects of the NHS National Cancer Data Project. Br J Dermatol 2003 149 : 1089 91.
15. Potter S, Govindarajulu S, Shere M et al. Referral patterns, cancer diagnoses, and waiting times after introduction of two week wait rule for breast cancer: prospective cohort study. BMJ 2007 335 : 288 90.
16. Jiwa M, Saunders C. Fast track referral for cancer. Has not improved patient outcomes in the U.K. BMJ 2007 335 : 267 8.